Test Methodology
Pyrosequencing (PSQ) is used for
Mycobacterium tuberculosis complex (MTBC) identification and
M. bovis differentiation.
Following molecular targets are detected by this PSQ assay:
- IS6110 is used for identification of
Mycobacterium tuberculosis complex.
- pncA is used for identification of
Mycobacterium bovis. This assay does not differentiate between
M. bovis and
M. bovis BCG.
Please contact the laboratory for more information on pyrosequencing method.
Reflex Testing Criteria
None
Pre-Approval Required
Pre-approval is required for the following:
- Specimen is AFB-negative
- Submission of sterile body fluids/specimens
- Duplicate submission, i.e., samples from the same patient collected within 2 months from prior collection date, if no prior approval was received.
Supplemental Information and Required Form(s)
Form LAB 444 (PDF) āMycobacteriology-Drug Susceptibility Testing of MTBC (CA only)ā
Instructions of completing this form.
Required Specimens/Sample Type(s)
Sediments or cultures are acceptable.
Processed sediment. Concentrated specimens from pulmonary and extra-pulmonary sources, including sputum, bronchial alveolar lavage, pleural fluid, CSF, abscess, gastric aspirate, urine, and tissues are acceptable.
Unprocessed clinical specimens should not be submitted. Submission of specimens from sterile body sites requires pre-approval.
Sediment should be confirmed to be AFB-positive (at least 1+); smear-negative specimens need approval prior to submission.
Culture on solid or in liquid media.
Minimum Volume Required
Sediments: 0.5mL; 1.0 mL is preferred
Culture in broth: 0.5 mL; 1.0 mL is preferred
Culture on solid media: visible growth is desired
Specimen Stability
Sediments:
Room Temp: not acceptable
Refrigerated (2 ā 8Ā°C): up to 30 days
Frozen (ā¤ -70Ā°C): up to 120 days
Cultures:
Room Temp: up to 30 days
Refrigerated: 2 ā 8Ā°C: up to 6 months; isolate may be subcultured
Frozen: Subculture prior to submission
Rejection Criteria
- Specimens with insufficient or conflicting labelling
- Leaking specimens
- Specimens with insufficient quantities
- Specimens that are too old
- Specimens improperly stored or transported
- Formalin fixed tissue and other specimen/sample types not meeting acceptance criteria
- Duplicate submission, i.e., samples from the same patient collected within 2 months from prior collection date, if no prior approval was received.
Storage/Transport Conditions
Sediment: Refrigerated or frozen.
Cultures: Grow isolate under appropriate conditions. Isolates may be stored under refrigeration or ambient temperature prior to shipping.
Transport Medium, if applicable
Not applicable
Specimen Labeling
Two identifiers, including patient full name, and at least one other identifier (specimen accession number, date of birth, medical record number).
Shipping Instructions and Specimen Handling Requirements
Ship diagnostic specimen with cold packs (do not freeze). Ship cultures at ambient temperature (do not freeze).
Follow the appropriate DOT/IATA approved shipping procedures. All the suspected MTBC human specimens should be shipped as a Biological Substance, Category B (UN3373).
Suspected or confirmed MTBC cultures should be shipped as a Category A Infectious Substance, Affecting Humans (UN2814).
Ship to:
California Department of Public Health
Microbial Diseases Laboratory
ATTN: TB Drug Susceptibility Testing Unit
850 Marina Bay Parkway, Specimen Receiving Room B106
Richmond, CA 94804
Ensure that culture isolates are sent in media flask or tubes containing a screw-top cap that is additionally sealed with parafilm or tape for additional protection against leaking.
Specimen Collection Instructions, if applicable
Not applicable
Turnaround Time
1 to 3 days
Interferences & Limitations
This assay does not differentiate between
M. bovis and
M. bovis BCG.
Inhibitory substances in the specimen may prevent successful DNA amplification and pyrosequencing.
Reference Range
Not applicable
Additional Information
Identification of Mycobacterium bovis is encouraged because the epidemiology is different from that of Mycobacterium tuberculosis.
MDL Point of Contact
For pre-approval or questions regarding submissions, please email
CDPHTBDST@cdph.ca.gov or call the MMPDS Section at (510) 412-3929.